These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 22216174)
1. CD9 tetraspanin interacts with CD36 on the surface of macrophages: a possible regulatory influence on uptake of oxidized low density lipoprotein. Huang W; Febbraio M; Silverstein RL PLoS One; 2011; 6(12):e29092. PubMed ID: 22216174 [TBL] [Abstract][Full Text] [Related]
2. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. Han J; Hajjar DP; Febbraio M; Nicholson AC J Biol Chem; 1997 Aug; 272(34):21654-9. PubMed ID: 9261189 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of Glutathione Production Induces Macrophage CD36 Expression and Enhances Cellular-oxidized Low Density Lipoprotein (oxLDL) Uptake. Yang X; Yao H; Chen Y; Sun L; Li Y; Ma X; Duan S; Li X; Xiang R; Han J; Duan Y J Biol Chem; 2015 Sep; 290(36):21788-99. PubMed ID: 26187465 [TBL] [Abstract][Full Text] [Related]
6. Oxidized LDL-bound CD36 recruits an Na⁺/K⁺-ATPase-Lyn complex in macrophages that promotes atherosclerosis. Chen Y; Kennedy DJ; Ramakrishnan DP; Yang M; Huang W; Li Z; Xie Z; Chadwick AC; Sahoo D; Silverstein RL Sci Signal; 2015 Sep; 8(393):ra91. PubMed ID: 26350901 [TBL] [Abstract][Full Text] [Related]
7. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. Kunjathoor VV; Febbraio M; Podrez EA; Moore KJ; Andersson L; Koehn S; Rhee JS; Silverstein R; Hoff HF; Freeman MW J Biol Chem; 2002 Dec; 277(51):49982-8. PubMed ID: 12376530 [TBL] [Abstract][Full Text] [Related]
8. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. Podrez EA; Poliakov E; Shen Z; Zhang R; Deng Y; Sun M; Finton PJ; Shan L; Febbraio M; Hajjar DP; Silverstein RL; Hoff HF; Salomon RG; Hazen SL J Biol Chem; 2002 Oct; 277(41):38517-23. PubMed ID: 12145296 [TBL] [Abstract][Full Text] [Related]
9. CD36 associates with CD9 and integrins on human blood platelets. Miao WM; Vasile E; Lane WS; Lawler J Blood; 2001 Mar; 97(6):1689-96. PubMed ID: 11238109 [TBL] [Abstract][Full Text] [Related]
10. A CD36 transmembrane domain peptide interrupts CD36 interactions with membrane partners on macrophages and inhibits atherogenic functions. Huang W; Li R; Zhang J; Cheng Y; Ramakrishnan DP; Silverstein RL Transl Res; 2023 Apr; 254():68-76. PubMed ID: 36377115 [TBL] [Abstract][Full Text] [Related]
11. Adipocytes recognize and degrade oxidized low density lipoprotein through CD36. Kuniyasu A; Hayashi S; Nakayama H Biochem Biophys Res Commun; 2002 Jul; 295(2):319-23. PubMed ID: 12150950 [TBL] [Abstract][Full Text] [Related]
12. The ω-carboxyl group of 7-ketocholesteryl-9-carboxynonanoate mediates the binding of oxLDL to CD36 receptor and enhances caveolin-1 expression in macrophages. Li J; Yu C; Wang R; Xu J; Chi Y; Qin J; Liu Q Int J Biochem Cell Biol; 2017 Sep; 90():121-135. PubMed ID: 28789920 [TBL] [Abstract][Full Text] [Related]
13. Pivotal role for platelet-activating factor receptor in CD36 expression and oxLDL uptake by human monocytes/macrophages. Rios FJ; Gidlund M; Jancar S Cell Physiol Biochem; 2011; 27(3-4):363-72. PubMed ID: 21471725 [TBL] [Abstract][Full Text] [Related]
14. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. Boullier A; Gillotte KL; Hörkkö S; Green SR; Friedman P; Dennis EA; Witztum JL; Steinberg D; Quehenberger O J Biol Chem; 2000 Mar; 275(13):9163-9. PubMed ID: 10734051 [TBL] [Abstract][Full Text] [Related]
15. OxLDL or TLR2-induced cytokine response is enhanced by oxLDL-independent novel domain on mouse CD36. Xie C; Ng H; Nagarajan S Immunol Lett; 2011 Jun; 137(1-2):15-27. PubMed ID: 21281677 [TBL] [Abstract][Full Text] [Related]
16. Porphyromonas gingivalis lipopolysaccharide increases lipid accumulation by affecting CD36 and ATP-binding cassette transporter A1 in macrophages. Li XY; Wang C; Xiang XR; Chen FC; Yang CM; Wu J Oncol Rep; 2013 Sep; 30(3):1329-36. PubMed ID: 23835648 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM. Yu M; Jiang M; Chen Y; Zhang S; Zhang W; Yang X; Li X; Li Y; Duan S; Han J; Duan Y J Biol Chem; 2016 Aug; 291(33):16977-89. PubMed ID: 27358406 [TBL] [Abstract][Full Text] [Related]
18. Uptake of oxLDL and IL-10 production by macrophages requires PAFR and CD36 recruitment into the same lipid rafts. Rios FJ; Ferracini M; Pecenin M; Koga MM; Wang Y; Ketelhuth DF; Jancar S PLoS One; 2013; 8(10):e76893. PubMed ID: 24130805 [TBL] [Abstract][Full Text] [Related]
19. Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through α Kanaoka Y; Koga M; Sugiyama K; Ohishi K; Kataoka Y; Yamauchi A Toxicology; 2017 Apr; 380():62-71. PubMed ID: 28202387 [TBL] [Abstract][Full Text] [Related]
20. Oxidized LDL phagocytosis during foam cell formation in atherosclerotic plaques relies on a PLD2-CD36 functional interdependence. Ganesan R; Henkels KM; Wrenshall LE; Kanaho Y; Di Paolo G; Frohman MA; Gomez-Cambronero J J Leukoc Biol; 2018 May; 103(5):867-883. PubMed ID: 29656494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]